Kiwi Wealth Investments Limited Partnership’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-219,210
Closed -$14M 69
2023
Q2
$14M Sell
219,210
-36,073
-14% -$2.42M 0.87% 30
2023
Q1
$17.7M Buy
255,283
+5,805
+2% +$409K 1.15% 24
2022
Q4
$17.9M Buy
249,478
+179,082
+254% +$13.5M 1.19% 24
2022
Q3
$5.42M Hold
70,396
0.38% 72
2022
Q2
$5.42M Buy
70,396
+43,021
+157% +$3.28M 0.38% 72
2022
Q1
$2M Buy
+27,375
New +$1.84M 0.11% 170
2020
Q3
Sell
-180,927
Closed -$10.6M 237
2020
Q2
$10.6M Sell
180,927
-4,972
-3% -$297K 0.86% 35
2020
Q1
$10.4M Buy
185,899
+20,527
+12% +$1.25M 1.04% 27
2019
Q4
$10.6M Buy
165,372
+54,637
+49% +$3.13M 0.78% 34
2019
Q3
$5.62M Buy
+110,735
New +$5.2M 0.45% 59

Other funds holding BMY

Kiwi Wealth Investments Limited Partnership's BMY Position: Q3 2023 in Review

Kiwi Wealth Investments Limited Partnership sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 219,210 shares — an estimated $14M sold.

Kiwi Wealth Investments Limited Partnership first reported a position in BMY in Q3 2019 and held it in 10 quarters. The position peaked at $17.9M in Q4 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • Kiwi Wealth Investments Limited Partnership reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 219,210 Bristol-Myers Squibb shares in Q3 2023, an estimated $14M.
  • Kiwi Wealth Investments Limited Partnership first reported a position in Bristol-Myers Squibb in Q3 2019 and held it in 10 quarters.
  • Kiwi Wealth Investments Limited Partnership's Bristol-Myers Squibb position peaked at $17.9M in Q4 2022.
  • 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q3 2023, filed 14 Nov 2023.